A PEGylated hyaluronic acid conjugate for targeted cancer immunotherapy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shin, Jung Min | - |
dc.contributor.author | Oh, Se Jin | - |
dc.contributor.author | Kwon, Seunglee | - |
dc.contributor.author | Deepagan, V. G. | - |
dc.contributor.author | Lee, Minchang | - |
dc.contributor.author | Song, Seok Ho | - |
dc.contributor.author | Lee, Hyo-Jung | - |
dc.contributor.author | Kim, Suyeon | - |
dc.contributor.author | Song, Kwon-Ho | - |
dc.contributor.author | Kim, Tae Woo | - |
dc.contributor.author | Park, Jae Hyung | - |
dc.date.accessioned | 2021-09-02T21:57:16Z | - |
dc.date.available | 2021-09-02T21:57:16Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2017-12-10 | - |
dc.identifier.issn | 0168-3659 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/81195 | - |
dc.description.abstract | The cell-free approach to foreignizing tumor cells with non-self antigens has received increasing attention as a method to induce cytotoxic T lymphocyte (CTL)-mediated immunological rejection of tumors, because the clinical translation of the conventional CTL-based cancer immunotherapies has been limited by a complicated manufacturing process and autotransplantation. In this study, we prepared matrix metalloproteinase 9 (MMP9)-responsive polymeric conjugates consisting of PEGylated hyaluronic acid (HA) as the targeting moiety and ovalbumin (OVA) as the model foreign antigen. The MMP9-cleavable linker was introduced between PEG and the HA backbone to facilitate the detachment of the PEG corona from the conjugate at the tumor site. From the in vitro cellular uptake study, it was revealed that the conjugate was effectively taken up by the CD44-expressing TC-1 cancer cells in the presence of MMP9 via receptor-mediated endocytosis. When the conjugate was systemically administered into the tumor-bearing mice with endogenous OVA-specific CTLs, the tumor growth was markedly inhibited, which was attributed to the significant antigen presentation on the tumor cells. Overall, the MMP9-responsive conjugates bearing foreign antigens might have the potential as an alternative to CTL-based cancer immunotherapeutics. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCIENCE BV | - |
dc.subject | ADOPTIVE CELL TRANSFER | - |
dc.subject | DRUG-DELIVERY | - |
dc.subject | MATRIX METALLOPROTEINASES | - |
dc.subject | TUMOR MICROENVIRONMENT | - |
dc.subject | IN-VIVO | - |
dc.subject | THERAPY | - |
dc.subject | NANOPARTICLES | - |
dc.subject | RESPONSES | - |
dc.subject | PROGRESSION | - |
dc.title | A PEGylated hyaluronic acid conjugate for targeted cancer immunotherapy | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Song, Kwon-Ho | - |
dc.contributor.affiliatedAuthor | Kim, Tae Woo | - |
dc.identifier.doi | 10.1016/j.jconrel.2017.08.032 | - |
dc.identifier.scopusid | 2-s2.0-85033234966 | - |
dc.identifier.wosid | 000417328600017 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CONTROLLED RELEASE, v.267, pp.181 - 190 | - |
dc.relation.isPartOf | JOURNAL OF CONTROLLED RELEASE | - |
dc.citation.title | JOURNAL OF CONTROLLED RELEASE | - |
dc.citation.volume | 267 | - |
dc.citation.startPage | 181 | - |
dc.citation.endPage | 190 | - |
dc.type.rims | ART | - |
dc.type.docType | Article; Proceedings Paper | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | ADOPTIVE CELL TRANSFER | - |
dc.subject.keywordPlus | DRUG-DELIVERY | - |
dc.subject.keywordPlus | MATRIX METALLOPROTEINASES | - |
dc.subject.keywordPlus | TUMOR MICROENVIRONMENT | - |
dc.subject.keywordPlus | IN-VIVO | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | NANOPARTICLES | - |
dc.subject.keywordPlus | RESPONSES | - |
dc.subject.keywordPlus | PROGRESSION | - |
dc.subject.keywordAuthor | Cancer immunotherapy | - |
dc.subject.keywordAuthor | Foreignization | - |
dc.subject.keywordAuthor | Antigen delivery | - |
dc.subject.keywordAuthor | Hyaluronic acid | - |
dc.subject.keywordAuthor | PEGylation | - |
dc.subject.keywordAuthor | Matrix metalloproteinase 9 (MMP9) | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.